Viewing Study NCT04991116


Ignite Creation Date: 2025-12-26 @ 11:49 AM
Ignite Modification Date: 2025-12-26 @ 11:49 AM
Study NCT ID: NCT04991116
Status: RECRUITING
Last Update Posted: 2025-10-27
First Post: 2021-07-29
Is NOT Gene Therapy: False
Has Adverse Events: False

Brief Title: Long Term Evaluation of Safety and Efficacy of Tildrakizumab in Patients With Psoriatic Arthritis
Sponsor: Sun Pharmaceutical Industries Limited
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module